BCL2 and cancer: Overexpression of anti-apoptotic Bcl-2 and Bcl-xL proteins rendered HCC cells more resistant to chemotherapeutic agents, such as staurosporine, Dox, and paclitaxel, in human HCC whereas reduced level of Bcl-2 sensitized cancer cells to these agents [13–15].